Bank of Montreal’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-429,600
| Closed | -$608K | – | 3596 |
|
2024
Q3 | $608K | Buy |
+429,600
| New | +$608K | ﹤0.01% | 2015 |
|
2023
Q3 | – | Sell |
-188,722
| Closed | -$2.06M | – | 3781 |
|
2023
Q2 | $2.06M | Sell |
188,722
-163,106
| -46% | -$1.78M | ﹤0.01% | 1534 |
|
2023
Q1 | $2.53M | Sell |
351,828
-68,572
| -16% | -$494K | ﹤0.01% | 1414 |
|
2022
Q4 | $1.68M | Buy |
420,400
+68,700
| +20% | +$275K | ﹤0.01% | 1579 |
|
2022
Q3 | $2.48K | Hold |
351,700
| – | – | ﹤0.01% | 1435 |
|
2022
Q2 | $1.79K | Hold |
351,700
| – | – | ﹤0.01% | 1646 |
|
2022
Q1 | $3.63M | Sell |
351,700
-14,600
| -4% | -$151K | ﹤0.01% | 1323 |
|
2021
Q4 | $4.52M | Sell |
366,300
-49,523
| -12% | -$611K | ﹤0.01% | 1229 |
|
2021
Q3 | $4.79M | Buy |
+415,823
| New | +$4.79M | ﹤0.01% | 1524 |
|
2021
Q2 | – | Sell |
-865
| Closed | -$13K | – | 4695 |
|
2021
Q1 | $13K | Sell |
865
-2,983
| -78% | -$44.8K | ﹤0.01% | 3850 |
|
2020
Q4 | $47K | Buy |
3,848
+2,788
| +263% | +$34.1K | ﹤0.01% | 3509 |
|
2020
Q3 | $15K | Sell |
1,060
-623
| -37% | -$8.82K | ﹤0.01% | 3550 |
|
2020
Q2 | $16K | Buy |
+1,683
| New | +$16K | ﹤0.01% | 3593 |
|
2020
Q1 | – | Sell |
-1,641
| Closed | -$14K | – | 4235 |
|
2019
Q4 | $14K | Buy |
1,641
+544
| +50% | +$4.64K | ﹤0.01% | 3942 |
|
2019
Q3 | $7K | Buy |
1,097
+44
| +4% | +$281 | ﹤0.01% | 4004 |
|
2019
Q2 | $17K | Buy |
1,053
+969
| +1,154% | +$15.6K | ﹤0.01% | 3805 |
|
2019
Q1 | $1K | Sell |
84
-44
| -34% | -$524 | ﹤0.01% | 3810 |
|
2018
Q4 | $1K | Buy |
128
+65
| +103% | +$508 | ﹤0.01% | 4209 |
|
2018
Q3 | $3K | Sell |
63
-2
| -3% | -$95 | ﹤0.01% | 3943 |
|
2018
Q2 | $2K | Buy |
+65
| New | +$2K | ﹤0.01% | 4084 |
|